Siren »

Amylyx Pharmaceuticals shares owned by Siren

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Siren from 13F filings

Historical chart of Siren investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Siren

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 1.2M 13.90

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Edgewise Therapeutics (EWTX)
BeOne Medicines Sponsored Ads (ONC)
Tango Therapeutics (TNGX)
Bicara Therapeutics (BCAX)
Revolution Medicines (RVMD)
Arrowhead Pharmaceuticals (ARWR)
Veradermics Common Stock (MANE)
Xenon Pharmaceuticals (XENE)
Olema Pharmaceuticals (OLMA)
Crinetics Pharmaceuticals In (CRNX)
Lexicon Pharmaceuticals Com New (LXRX)
Cogent Biosciences (COGT)

View all positions for Siren

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Commodore Capital
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
Adage Capital Partners GP
First Light Asset Management
Driehaus Capital Management
Goldman Sachs Group
State Street Corporation
Franklin Resources
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals